New WHO publication: Xpert MTB/RIF implementation manual

Technical and operational ‘how-to’: practical considerations

Read More →

Brook Baker and Yousuf Vawda: Academics for TAC

We urge other academics, in South Africa and globally, to support the Treatment Action Campaign and its vital work with both your financial and intellectual assets. The TAC is the heart of the international AIDS movement – we cannot sit by and let that heartbeat still.

Read More →

Global Fund: NFM allocations: An Aidspan analysis

The allocations provided by the Global Fund to countries for 2014-2017 amount to $14.67 billion. The breakdown by type of component is as follows: HIV 52% ($7.64 billion), malaria 29% ($4.26 billion), TB 17% ($2.50 billion) and health systems strengthening 2% ($281 million).

Read More →

South Africa: DR-TB patients, activists demand registering generic linezolid

A letter, signed by over 100 clinicians, organisations and patients with DR-TB, demands the immediate registration of a generic version of linezolid in South Africa, which has been under a significantly delayed fast-track review process since May 2013.

Read More →

Key advocacy fact sheets on TB in Europe released in English and Russian

The three new fact sheets on “Ambulatory TB care”, “Integrated TB/HIV care” and “Engaging civil society and affected communities in the fight against TB” aim to share best practices from the European region on the three topics.

Read More →

The Union to test all-oral treatment option for multidrug-resistant TB

New treatment regimen is first-ever injection-free regimen tested to date.

Read More →

Changing the status quo: investing in communities to beat TB

We need support to train, equip and empower civil society leaders to form a movement that stretches both within and beyond national borders.

Read More →

TB activists call for a bigger piece of the pie from the Global Fund

Today TB activists interrupted the plenary session at the 45th Conference on Lung Health, calling on the Global Fund and partners to increase the amount of funds allocated to TB without jeopardizing funding to HIV and malaria and other diseases.

Read More →

Activists urge Otsuka to provide access to TB drug

TB activists interrupted Otsuka’s symposium at the 45th Conference on Lung Health, calling for widespread registration of and immediate broad compassionate use access to delamanid, Otsuka’s new drug to treat multidrug-resistant TB.

Read More →

WHO guidelines on the management of latent tuberculosis infection launched at the 45th Conference on Lung Health

For the first time, the World Health Organization has issued guidelines on testing, treating and managing latent TB infection in individuals with high risk of developing disease.

Read More →

Page 1 of 48 · Total posts: 10

1 2 Last→